Spyre (SYRE)

Cytospire Therapeutics

This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.

Prometheus Biosciences

This biotechnology company develops precision medicine therapies and companion diagnostic tests for patients with inflammatory bowel disease and other immune-mediated conditions.

Cytospire

This biotechnology company develops multispecific immune cell engager antibodies to treat patients with solid and liquid tumours.

Inhibrx

Inhibrx Biosciences develops biologic therapeutic candidates for patients with various cancers and rare diseases using its proprietary single-domain antibody platform.

Spero

This biopharmaceutical company develops medicines for immune-mediated diseases and multi-drug resistant bacterial infections for patients with unmet medical needs.

Dyne

This company develops therapeutics for patients with genetically driven neuromuscular diseases.

Tourmaline Bio

This biotechnology firm develops antibody therapeutics for patients with immune and inflammatory conditions, including atherosclerotic cardiovascular disease and thyroid eye disease.

cAMPfield

The company develops oral biopharmaceutical medicines for patients with immune-mediated inflammatory diseases, specifically focusing on treatments for inflammatory bowel disease.